Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$9.99 - $14.91 $1,698 - $2,534
-170 Reduced 30.8%
382 $5.35 Million
Q4 2023

Mar 01, 2024

BUY
$7.6 - $10.53 $4,195 - $5,812
552 New
552 $5.81 Million

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $608M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Creekmur Asset Management LLC Portfolio

Follow Creekmur Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creekmur Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Creekmur Asset Management LLC with notifications on news.